Literature DB >> 26653561

The tumor-suppressor gene LZTS1 suppresses hepatocellular carcinoma proliferation by impairing PI3K/Akt pathway.

Yonghong He1, Xia Liu2.   

Abstract

BACKGROUND: To study the role of LZTS1 in hepatocellular carcinoma (HCC) proliferation and the molecular mechanism involved.
METHODS: LZTS1 expression was studied in 10 HCC cell lines and 1 normal hepatocyte cell line by western blot analysis and qRT-PCR. One HCC cell line was selected and transfected with LZTS1 lentivirus. Cell proliferation and cell cycle were then determined by CCK-8 assay and flow cytometry, respectively. LZTS1, cyclin D1, CDK1, Cdc25C, pS473 Akt, and pT308 Akt mRNA and protein expressions were measured. PS473 Akt and pT308 Akt expression level was also compared with the HCC cells treated with LY294002.
RESULTS: Compared with the normal hepatocyte cells, LZTS1 expression in HCC cells was significantly lower. After the transfection with LZTS1 lentivirus, HCC cell proliferation ability decreased markedly and HCC cells were blocked at G2/M phase. Cyclin D1 and CDK1 expression were both decreased but not significantly. Cdc25C expression was increased significantly. PS473 Akt and pT308 Akt expression level was increased significantly as well, which were almost the same with those transfected with LY294002.
CONCLUSION: LZTS1 could inhibit HCC cell proliferation by impairing PI3K/Akt pathway.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cell proliferation; Hepatocellular carcinoma; LZTS1; PI3K/Akt

Mesh:

Substances:

Year:  2015        PMID: 26653561     DOI: 10.1016/j.biopha.2015.10.006

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  MiR-762 regulates the activation of PI3K/AKT and Hippo pathways involved in the development of gastric cancer by targeting LZTS1.

Authors:  Kuaiyun Yu; Heng Zhu
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

2.  Promotive effects of bone morphogenetic protein 2 on angiogenesis in hepatocarcinoma via multiple signal pathways.

Authors:  Wei-Han Zuo; Peng Zeng; Xi Chen; Yan-Jun Lu; An Li; Jian-Bin Wu
Journal:  Sci Rep       Date:  2016-11-25       Impact factor: 4.379

Review 3.  Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals.

Authors:  Seung Wan Son; Han Yeoung Lee; Sokviseth Moeng; Hyo Jeong Kuh; Soo Young Choi; Jong Kook Park
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

4.  Long non-coding RNA Lnc-LALC facilitates colorectal cancer liver metastasis via epigenetically silencing LZTS1.

Authors:  Chuan Zhang; Lu Wang; Chi Jin; Jiahui Zhou; Chaofan Peng; Yong Wang; Ziwei Xu; Dongsheng Zhang; Yuanjian Huang; Yue Zhang; Dongjian Ji; Wen Peng; Kangpeng Jin; Junwei Tang; Yifei Feng; Yueming Sun
Journal:  Cell Death Dis       Date:  2021-02-26       Impact factor: 8.469

5.  Identification of Prognostic Factors in Cholangiocarcinoma Based on Integrated ceRNA Network Analysis.

Authors:  Haili Jin; Wei Liu; Weiming Xu; Liping Zhou; Huarong Luo; Cheng Xu; Xi Chen; Wenbin Chen
Journal:  Comput Math Methods Med       Date:  2022-09-15       Impact factor: 2.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.